Full text loading...
- ISSN: 1389-5575
- E-ISSN: 1875-5607
-
Development of Miltefosine for the Leishmaniases
- Source: Mini Reviews in Medicinal Chemistry, Volume 6, Issue 2, Feb 2006, p. 145 - 151
-
- 01 Feb 2006
Abstract
The leishmaniases consist of visceral and cutaneous syndromes present in > 30 endemic regions of the world. Miltefosine (hexadecylephosphocholine) is the first oral agent that is effective and tolerated for both visceral and cutaneous disease in several endemic regions, and represents a major advance in the treatment of these diseases.
© Bentham Science Publishers